TYBOURNE CAPITAL MANAGEMENT (HK) LTD 13F Holdings

Read this manager's filing book

Step 1 of 3

Disclosed positions

TYBOURNE CAPITAL MANAGEMENT (HK) LTD: source evidence dated 2025-11-07T04:59:59.999Z.

Issuer: TAYSHA GENE THERAPIES INC (TSHA US)
Ticker: TSHA
Class: COM SHS
Reported value: $12,099,000
Reported amount: 3,700,000
Unit: SH
Option: None

What you should see

The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.

Step 2 of 3

What was reported for this quarter?

13F positions are dated quarter-end holdings, with later publication and possible amendments. Read report period and availability before calling them current.

SEC 13F-HR: 0001553936-25-000013

What you should see

Open the effective filing receipt and inspect shares, value and any put/call classification separately.

Step 3 of 3

Browse institutional filings

Open the effective filing receipt and inspect shares, value and any put/call classification separately.

Browse institutional filings

What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Disclosed positions

See the complete disclosed positions

Filter rows

Scroll sideways to compare all columns. Select a heading to sort.


TAYSHA GENE THERAPIES INC (TSHA US)	TSHA	COM SHS	$12,099,000	3,700,000	SH	None
FORTE BIOSCIENCES INC (FBRX US)	FBRX	COM NEW	$11,799,705	786,647	SH	None
ALUMIS INC (ALMS US)	ALMS	COM	$5,583,008	1,399,250	SH	None
ZENTALIS PHARMACEUTICALS INC (ZNTL US)	ZNTL	COM	$1,451,844	961,486	SH	None

Largest 50 positions by reported value; the filing may contain more positions.

How amendments affect these holdings

This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 0 positions lack a resolved ticker and 0 positions are put or call entries.

A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.

Quarter end and public filing date

Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.